Cost‐effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake
Cancer · 01.05.2026 · 132 (9)
DOI: 10.1002/cncr.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 25.04.2026. Verfasst von Florence K L Tangka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Mass Screening. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
The decrease in colorectal cancer (CRC) mortality over the past 2 decades is largely attributed to increased screening. This progress has not been evenly distributed across populations. Individuals who seek care at federally qualified health centers (FQHCs) have low CRC screening prevalence. This study aims to assess the effectiveness and cost of interventions to increase CRC screening at FQHCs, by using fecal immunochemical tests (FIT).
Methods
The authors evaluated changes in FIT screening uptake in eight FQHCs that participated in the Colorectal Cancer Control Program (CRCCP) before and after the multicomponent evidence‐based interventions were implemented. Examples of interventions included patient reminders, provider assessment and feedback, and patient navigation. They collected the labor and nonlabor cost of implementing the interventions. Furthermore, they used a validated microsimulation model to assess the long‐term cost‐effectiveness of the interventions.
Results
All eight FQHCs showed increases in CRC screening following the implementation of the multicomponent interventions, with an average increase of 14.4 percentage points (range, 4.9–26.7) and an average intervention cost of $14.40 per person (range, $5.76–$34.70). In five of the eight FQHCs, the interventions resulted in cost savings when public payer costs were considered. In the remaining three FQHCs, the cost per life years saved ranged from $14,898 to $54,111.
Conclusions
Multicomponent interventions to increase the use of FIT kits represent an effective and efficient strategy for increasing CRC screening uptake in FQHCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Implenomics, Durham, North Carolina, USA.
- RTI International, Durham, North Carolina, USA.
ORCID-Profile: Florence K L Tangka, Sujha Subramanian, Sonja Hoover, Kate O'Rourke
Förderung
- Intramural CDC HHS
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Tangka, F. K. L., Subramanian, S., Hoover, S., O'Rourke, K., Zirali, P., Preiss, A., Schlueter, D., Melillo, S., Coleman King, S., Joseph, D., & Richardson, L. C. (2026). Cost‐effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake. Cancer, 132(9). https://doi.org/10.1002/cncr.70436
Vancouver
Tangka FKL, Subramanian S, Hoover S, O'Rourke K, Zirali P, Preiss A, et al. Cost‐effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake. Cancer. 2026;132(9). doi:10.1002/cncr.70436
BibTeX
@article{Tangka2026,
author = {Tangka, Florence K L and Subramanian, Sujha and Hoover, Sonja and O'Rourke, Kate and Zirali, Praveen and Preiss, Alexander and Schlueter, Dara and Melillo, Stephanie and Coleman King, Sallyann and Joseph, Djenaba and Richardson, Lisa C},
title = {Cost‐effectiveness of interventions to increase colorectal cancer screening among populations with low screening uptake},
journal = {Cancer},
year = {2026},
volume = {132},
number = {9},
doi = {10.1002/cncr.70436}
}
EUVIMED